ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

The UMass Chan Medical School in Worcester announced Thursday it received a $35 million gift that aims to advance research to ...

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...

Fifteen U.S. nonprofit organizations formed a new ALS group, ALS United, to help address the needs of people living with ALS.

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

A new study led by researchers at Mass General Brigham suggests that different brain regions activated by creative tasks are ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...